Sign In securely
Haven't registered yet?
3/24/2017Stewardship / Resistance Scan for Mar 24, 2017
3/24/2017News Scan for Mar 24, 2017
3/24/2017CDC reports 7 more babies born with Zika defects
6/22/2017 » 6/25/20172017 OSAP Annual Conference
Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.
The vaccine, which is already approved for use in adults aged 50 and above, and children aged 6 weeks to 17 years, prevents invasive diseases caused by 13 Streptococcus pneumoniae strains.
OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.